Delivery Order SPE2DB20D2002-SPE2DB25FL51J
Award Date
6/23/25
Potential Completion Date
6/24/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,192.91 firm fixed-price contract is for the delivery of 180 capsules of MESALAMINE DR 400 MG. The contract has an ultimate completion date of May 22, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,991.84, is for the delivery of MESALAMINE DR 400 MG CAPSULE 180S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period running through February 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a $1,394.90 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract is for the supply of MESALAMINE DR 400 MG CAPSULE 180S, a medication used to treat gastrointestinal conditions. The contract has an ultimate completion date of May 19, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,382.57, is a delivery order for 4567178220 MESALAMINE DR 400 MG CAPSULE 180S. It is a firm fixed price contract with a completion date of February 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mesalamine DR 400 mg Capsule (180s). The contract has a ceiling value of $2,666.26 and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,167.46, is a delivery order for 4565265690 - MESALAMINE DR 400 MG CAPSULE 180S. The contract has an ultimate completion date of July 29, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, including Mesalamine DR 400 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,272.71 and a completion date of July 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This contract award, valued at $1,351.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MESALAMINE DR 400 MG CAPSULE 180S, a specialty medication, with a completion date of May 10, 2023. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,093,215 units of Mesalamine DR 400 mg capsules. The contract has a ceiling value of $4,230.04 and a performance period through May 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.80 firm fixed-price delivery order covers the procurement of 4,567,343,614 units of Mesalamine DR 400 mg capsules. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...